Nursing Education and Collaborative Learning
Launched by NAMIK KEMAL UNIVERSITY · Sep 5, 2023
Trial Information
Current as of August 31, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a special teaching method called collaborative learning can help nursing students become better thinkers and learners. Collaborative learning means that students work together and help each other, which can make learning more effective and engaging. The goal of the study is to see if this approach can improve students' creativity and their ability to manage their own learning, which is important for their future careers in nursing.
To participate in this trial, students need to be in their third year of nursing school and have completed certain courses like basics of nursing and internal medicine nursing. They must also choose to take part in the study and have attended all classes. Unfortunately, students from other years or those who miss classes won’t be able to join. If selected, participants can expect to take part in a nursing education course that uses this collaborative learning model, potentially enhancing their skills and preparing them better for their future roles in healthcare.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Third-year students who took the course basics of nursing, internal medicine nursing, physiology, pathology, and who voluntarily participated in the study and were not absent were included in the study.
- Exclusion Criteria:
- • Students in other classes
- • Those who do not volunteer to participate in the research
- • Students who are absent
About Namik Kemal University
Namik Kemal University is a leading academic institution dedicated to advancing research and education in the health sciences. With a commitment to innovation and excellence, the university actively sponsors clinical trials aimed at enhancing patient care and developing new therapeutic approaches. Leveraging its state-of-the-art facilities and a team of experienced researchers, Namik Kemal University fosters collaborative partnerships that drive scientific discovery and contribute to the body of knowledge in clinical medicine. Through its rigorous research programs, the university aims to improve health outcomes and address pressing medical challenges, making a significant impact on both local and global health communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Dilek Erden, PhD.
Principal Investigator
Namik Kemal University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported